Martin P Lefkowitz
Overview
Explore the profile of Martin P Lefkowitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
5574
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kondo T, Jhund P, Anand I, Claggett B, Desai A, Docherty K, et al.
JACC Heart Fail
. 2025 Mar;
PMID: 40088233
Background: Recent trials of new heart failure (HF) treatments suggest the effect of therapy may vary by N-terminal pro-B type natriuretic peptide (NT-proBNP) level. Objectives: The authors examined the efficacy...
2.
Yang M, Kondo T, Dewan P, Desai A, Lam C, Lefkowitz M, et al.
Circ Heart Fail
. 2025 Mar;
:e011598.
PMID: 40026147
Background: How different combinations of comorbidities influence risk at the patient level and population level in patients with heart failure with mildly reduced ejection fraction/heart failure with preserved ejection fraction...
3.
Mc Causland F, Vaduganathan M, Claggett B, Gori M, Jhund P, McGrath M, et al.
JACC Heart Fail
. 2024 Nov;
13(1):105-114.
PMID: 39570234
Background: Lower estimated glomerular filtration rate (eGFR) may be one of the major reasons for hesitation or failure to initiate potentially beneficial therapies in patients with heart failure (HF). Objectives:...
4.
Shen L, Dewan P, Ferreira J, Cunningham J, Jhund P, Anand I, et al.
Circulation
. 2024 Oct;
150(24):1913-1927.
PMID: 39429145
Background: Cognitive impairment is common in patients with heart failure and preserved ejection fraction but its clinical correlates and prognostic associations are poorly understood. Methods: We analyzed cognitive function, using...
5.
Matsumoto S, Shen L, Henderson A, Bohm M, Desai A, Kober L, et al.
J Am Coll Cardiol
. 2024 Sep;
84(18):1685-1700.
PMID: 39320292
Background: Hypotension is an important clinical problem in heart failure (HF). Objectives: This study sought to examine the association between asymptomatic vs symptomatic hypotension and outcomes in PARADIGM-HF (Prospective Comparison...
6.
Chatur S, Beldhuis I, Claggett B, McCausland F, Neuen B, Desai A, et al.
JACC Heart Fail
. 2024 Jun;
12(10):1692-1703.
PMID: 38842957
Background: Sacubitril/valsartan is a foundational therapy for patients with heart failure. Although current U.S. Food and Drug Administration labeling does not provide guidance regarding initiation or continuation of sacubitril/valsartan in...
7.
Dewan P, Shen L, Ferreira J, Jhund P, Anand I, Chandra A, et al.
Circulation
. 2024 Jun;
150(4):272-282.
PMID: 38841854
Background: A hypothetical concern has been raised that sacubitril/valsartan might cause cognitive impairment because neprilysin is one of several enzymes degrading amyloid-β peptides in the brain, some of which are...
8.
Chatur S, Neuen B, Claggett B, Beldhuis I, Mc Causland F, Desai A, et al.
J Am Coll Cardiol
. 2024 Apr;
83(22):2148-2159.
PMID: 38588927
Background: The Kidney Disease Improving Global Outcomes (KDIGO) classification integrates both estimated glomerular filtration rate and urine-albumin-creatinine ratio to stratify risk more comprehensively in patients with chronic kidney disease. There...
9.
Tolomeo P, Butt J, Kondo T, Campo G, Desai A, Jhund P, et al.
Eur J Heart Fail
. 2023 Dec;
26(2):245-256.
PMID: 38124454
Aim: Blood urea nitrogen (BUN) to creatinine ratio is associated with worse outcomes in acute heart failure (HF) but little is known about its importance in chronic HF. Methods And...
10.
Butt J, McDowell K, Kondo T, Desai A, Lefkowitz M, Packer M, et al.
ESC Heart Fail
. 2023 Oct;
11(1):65-77.
PMID: 37813587
Aims: Red cell distribution width (RDW) is a strong prognostic marker in patients with heart failure (HF) and reduced ejection fraction and other conditions. However, very little is known about...